TI
BSX icon

Trexquant Investment’s Boston Scientific BSX Stock Holding History

Trexquant Investment’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$935K Buy
21,900
+13,400
+158% +$728K 0.01% 1486
2026
Q1 		$533K Buy
+8,500
New +$680K ﹤0.01% 1450

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Trexquant Investment's BSX Position: Q2 2026 in Review

Trexquant Investment increased its Boston Scientific (BSX) stake by 203% in Q2 2026, buying an estimated $42.6M and bringing the position to 1,169,741 shares worth $49.9M. The position accounts for 0.29% of the portfolio, ranked #43.

Trexquant Investment first reported a position in BSX in Q4 2014 and has held it in 34 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Trexquant Investment held 1,169,741 shares of Boston Scientific worth $49.9M as of Q2 2026.
  • Trexquant Investment bought 784,250 Boston Scientific shares in Q2 2026, an estimated $42.6M.
  • Boston Scientific made up 0.29% of Trexquant Investment's portfolio in Q2 2026, its #43 holding.
  • Trexquant Investment first reported a position in Boston Scientific in Q4 2014 and has held it in 34 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.